Thomas G. Gross

Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

János Sümegi, Dali Huang, Árpád Lányi et al. · PubMed · 2000 · 236 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

Sonali M. Smith, Linda J. Burns, Koen van Besien et al. · Journal of Clinical Oncology · 2013 · 230 citations · Full text

Medicine, Hematology, Oncology +14

De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General Population

Yun Miao, J Everly, Thomas G. Gross et al. · Transplantation · 2009 · 227 citations

Medicine, Oncology, Surgery +17

Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children’s Oncology Group Report

Thomas G. Gross, Manuela Orjuela, S L Perkins et al. · American Journal of Transplantation · 2012 · 188 citations · Full text

Medicine, Oncology, Pediatrics +16

Low-Dose Chemotherapy for Epstein-Barr Virus–Positive Post-Transplantation Lymphoproliferative Disease in Children After Solid Organ Transplantation

Thomas G. Gross, John C. Bucuvalas, Julie R. Park et al. · Journal of Clinical Oncology · 2005 · 185 citations

Medicine, Immunology, Oncology +13